Summer Seminar Session 4
We will be discussing AD plasma biomarkers in participants with Down syndrome. Many of our discussions in the past few weeks have centered around how comorbidities and enhanced risk may […]
We will be discussing AD plasma biomarkers in participants with Down syndrome. Many of our discussions in the past few weeks have centered around how comorbidities and enhanced risk may […]